Close Menu
Earth & BeyondEarth & Beyond

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    This Is Lorelei Announces Album, Shares New Version of “Name the Band”: Listen

    Trinidad Chambliss: Division II Ferris State to breakout star at Ole Miss

    The West shows up as G2 and FlyQuest move one step closer to Worlds 2025 Knockouts

    Facebook X (Twitter) Instagram
    Earth & BeyondEarth & Beyond
    YouTube
    Subscribe
    • Home
    • Business
    • Entertainment
    • Gaming
    • Health
    • Lifestyle
    • Sports
    • Technology
    • Trending & Viral News
    Earth & BeyondEarth & Beyond
    Subscribe
    You are at:Home»Technology»How political attacks could crush the mRNA vaccine revolution
    Technology

    How political attacks could crush the mRNA vaccine revolution

    Earth & BeyondBy Earth & BeyondMay 11, 2025009 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    How political attacks could crush the mRNA vaccine revolution
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The day after Donald Trump moved back into the White House in January, he celebrated a US$500-billion private-sector investment in artificial intelligence (AI) with a high-profile announcement in the Roosevelt Room. The new president looked on as technology billionaire Larry Ellison highlighted one of the initiative’s most transformative goals: using messenger RNA vaccines to transform cancer treatments.

    By harnessing AI to analyse tumour genetics, Ellison explained, researchers could rapidly design personalized vaccines tailored to an individual’s cancer. “This is the promise of AI and the promise of the future,” he said.

    Are the Trump team’s actions affecting your research? How to contact Nature

    Biotechnology executives were elated. Trump had, just five years earlier, propelled mRNA medicines into the spotlight through his signature effort to fast-track the development of a coronavirus vaccine. Now, just one day into his second term, he was once again elevating the technology to the national stage.

    “Then the bottom fell out,” says Deborah Day Barbara, co-founder of the Alliance for mRNA Medicines (AMM), a trade group representing more than 75 companies and academic institutions that are advancing mRNA research, development and manufacturing.

    A prominent vaccine critic who had vilified the mRNA-based COVID-19 jabs, Robert F. Kennedy Jr, was appointed to lead the country’s top health agency, and long-time champions of immunization science in the civil-service sector were shown the door. Research grants tied to HIV prevention and pandemic preparedness were abruptly cancelled, including many involving mRNA. And numerous other projects that were focused on mRNA vaccine technology were compiled into a list, potentially signalling their impending termination.

    At the same time, legislators in several states have been pushing to ban or restrict the use of mRNA-based medicines for infectious diseases. None of these measures has become law, but the efforts threaten to destabilize the mRNA industry, creating uncertainty and potentially limiting patient access to emerging treatments.

    The anti-mRNA sentiment — coupled with the sweeping shake-up of science funding across the United States — has sparked fears that this once-celebrated technology, widely seen as a major engine of next-generation vaccines and therapeutics, could soon find itself on the chopping block.

    For AMM executive director Clay Alspach, a principal at Leavitt Partners, a health-care consulting firm in Washington DC, the message has been unmistakable: “This is an existential threat,” he says.

    By mid-March, the AMM was holding regular conference calls to strategize. Members swapped intelligence, compared notes on delayed grants and tried to anticipate what might come next. Amid the uncertainty, a few questions loomed large: how far would the clampdown on mRNA go? Would it stop at COVID-19 jabs? Would it extend to all vaccines in development for influenza and other infectious threats? Or reach even into mRNA-based drug therapies in the works for cancer, autoimmune disorders, rare genetic diseases and more?

    From hero to zero

    Five years ago, the US government was spending billions of dollars to support the development, manufacturing and roll-out of mRNA vaccines, which played a major part in curbing the COVID-19 pandemic. Pharmaceutical companies were pouring in capital and building ambitious pipelines centred on mRNA. The technology was feted with a Nobel prize. Investor confidence was sky-high.

    Now, in the span of just a few months, the mood across the industry has grown darker — chilled by a newly hostile political climate.

    Will US science survive Trump 2.0?

    One contract manufacturer of mRNA products has seen a substantial decline in business as government-backed vaccine programmes have their funding pulled, according to a senior company executive. Another biotech executive says that his mRNA-focused company is considering relocating planned clinical trials for anti-viral vaccines to outside the United States — or scrapping them entirely, shifting the firm’s focus to less politically volatile therapeutic areas. “It’s all just a commercial and regulatory risk now,” he says.

    Both executives requested anonymity to avoid drawing political attention to their companies — but their experiences reflect a broad upheaval that is now rippling through the industry. In a survey released this month by the AMM, nearly half of 106 senior biotech and pharma executives reported direct impacts from US policy shifts this year — including project downsizing, budget cuts, delayed investments, terminated partnerships, job losses, hiring freezes and planned relocation of operations overseas1 (see ‘An industry at risk’).

    An industry at risk. Charts showing how the life-science industry has been impacted by the US policies.

    Source: Ref. 1

    Much of the current antipathy towards mRNA vaccines can be traced back to the COVID-19 pandemic, and the political and cultural backlash it left in its wake. Critics cite the compressed timelines and emergency use authorizations as signs that the safety of the vaccines was compromised. Vaccine mandates — imposed by governments, employers and schools — further fuelled resentment. Meanwhile, conspiracy theories about DNA alteration and population control continue to circulate widely online, deepening public mistrust and giving political traction to opposition against mRNA technology.

    What began as fringe scepticism has increasingly entered the mainstream consciousness, amplified by partisan media and political figures who frame the vaccines not as public-health tools but as symbols of government overreach. Among the most prominent of these is Kennedy, now secretary of the US Department of Health and Human Services (HHS), who has long questioned the safety of childhood immunizations and built his political brand on vaccine resistance. (HHS officials did not respond to requests for comment. A spokesperson for the White House pointed to a public statement that did not address the questions posed by Nature.)

    Exclusive: NIH to terminate hundreds of active research grants

    There are some conservative voices who are more supportive of mRNA technology — for example, a February report2 from the Texas Conservative Coalition Research Institute, a public-policy organization in Austin, urges policymakers to recognize the technology’s broad potential in medicine and agriculture. But those views have been mostly drowned out by more extreme rhetoric.

    Even the term ‘mRNA’ has become a political lightning rod; its charged connotations now influence scientific discourse and health policy far beyond the vaccine debate. “That paranoia has gotten wrapped into mRNA as a word,” says Jeff Coller, an RNA biologist at Johns Hopkins University in Baltimore, Maryland, who is also involved in several small biotech firms.

    Seeking to reframe the narrative, Coller and others are mobilizing around a strategic communications offensive, emphasizing mRNA’s potential not just in thwarting infectious threats but also in treating many of the same chronic conditions targeted by Kennedy’s ‘Make America Healthy Again’ initiative. The campaign to rehabilitate mRNA’s reputation starts at the top: with appeals to Trump’s legacy as a champion of medical innovation.

    Legacy on the line

    AMM leaders are preparing to publish a series of editorials that make the case that Trump’s decisive leadership during Operation Warp Speed — the 2020 programme that delivered COVID-19 vaccines in record time — marked the beginning of a new chapter in biotechnology and positioned the United States at the forefront of what many see as the fourth great wave of pharmaceutical innovation, after small-molecule drugs, biologics and cell and gene therapies.

    Framing it as a chance for Trump to cement his place in medical history, they are urging the president to build on the foundation that he helped to lay. In particular, they pointed out that, by supporting mRNA-based cancer treatments, he could achieve a major unmet goal that was advanced by his predecessor Joe Biden, who had made “ending cancer as we know it” a signature priority. Trump “could be the president who is a true visionary on cancer”, says Coller, a leading academic voice at the AMM.

    People in masks wait in line at a free covid-19 walk-up vaccination site in Washington, DC, U.S. during the pandemic.

    People queue for COVID-19 vaccinations in Washington DC.Credit: Jim Watson/AFP via Getty

    Such messaging just might resonate. Although Trump criticized the roll-out and mandates surrounding the COVID-19 vaccines in the period between his two terms, allies say he remains proud of the part he played in accelerating the technology’s development. “President Trump believes that Operation Warp Speed was a roaring success, and that the COVID mRNA vaccines were his great achievements,” says Robert Malone, a scientist involved in foundational mRNA research and a high-profile voice in conservative-leaning health-policy circles.

    But leading the charge against mRNA technology are individuals in the ‘medical freedom movement’ — Kennedy chief among them. They contend that COVID-19 vaccines were rushed through approval without adequate long-term testing, alleging that safety corners were cut in the name of speed, and that the risks of mRNA platforms continue to be deliberately downplayed.

    At his confirmation hearing earlier this year, for example, Kennedy — who previously described an mRNA-based COVID-19 jab as the “deadliest vaccine ever made” — persisted in claiming that the vaccine was recommended for young children “without any scientific basis”, despite published clinical-trial evidence3 to the contrary.

    Public-health researchers and vaccine scientists emphasize that mRNA vaccines have consistently demonstrated robust safety and effectiveness in preventing severe COVID-19 outcomes, supported by extensive data from rigorous clinical trials and real-world studies. Yet, with trust in institutions and in the biomedical establishment crumbling, some argue that pulling back from mRNA is the only responsible course of action — not because the science is flawed, but because the damage to public confidence is too deep.

    “If mRNA has a chance to have impact in the future, there needs to be a restoration of public trust around it,” says David Mansdoerfer, a political consultant in Fort Worth, Texas, and a former senior HHS official in the first Trump administration. To that end, he, like many associated with Kennedy, would support federal regulators withdrawing approval for all COVID-19 vaccines that initially entered the market under emergency-use provisions — including the mRNA-based ones that later won full approval. Mansdoerfer advocates re-evaluating the jabs under a standard review process.

    ‘The brand is damaged’

    The problem of mRNA’s reputation isn’t just a communications challenge — it’s a systemic liability. “I fear the brand is damaged for most uses,” wrote Vinay Prasad, a haematologist–oncologist at the University of California, San Francisco, in a Substack post in March. A vocal critic of COVID-19 vaccine mandates under Biden, Prasad was selected this month to lead the division of the US Food and Drug Administration that oversees vaccines and other biological products.

    The branding issue for mRNA is not just a problem in the United States either. An analysis of social-media data across 44 countries, published last year, found “widespread negative sentiment and a global lack of confidence in the safety, effectiveness and trustworthiness of mRNA vaccines and therapeutics”4.

    attacks crush mRNA Political revolution vaccine
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleTrump official says NJ Democrats could face charges
    Next Article Amid fragile ceasefire, Trump promises to boost trade with India and Pakistan | India
    Earth & Beyond
    • Website

    Related Posts

    Too burned out to travel? This new app fakes your summer vacation photos for you

    October 18, 2025

    The US has a new roadmap for fusion energy, without the funds to back it up

    October 18, 2025

    Is academic research becoming too competitive? Nature examines the data

    October 18, 2025
    Leave A Reply Cancel Reply

    Latest Post

    If you do 5 things, you’re more indecisive than most—what to do instead

    UK ministers launch investigation into blaze that shut Heathrow

    The SEC Resets Its Crypto Relationship

    How MLB plans to grow Ohtani, Dodger fandom in Japan into billions for league

    Stay In Touch
    • YouTube
    Latest Reviews

    Too burned out to travel? This new app fakes your summer vacation photos for you

    By Earth & BeyondOctober 18, 2025

    The US has a new roadmap for fusion energy, without the funds to back it up

    By Earth & BeyondOctober 18, 2025

    Is academic research becoming too competitive? Nature examines the data

    By Earth & BeyondOctober 18, 2025

    Subscribe to Updates

    Get the latest tech news from FooBar about tech, design and biz.

    Most Popular

    Bitcoin in the bush – crypto mining brings power to rural areas

    March 25, 202513 Views

    Israeli Police Question Palestinian Director Hamdan Ballal After West Bank Incident

    March 25, 20258 Views

    How to print D&D’s new gold dragon at home

    March 25, 20257 Views
    Our Picks

    This Is Lorelei Announces Album, Shares New Version of “Name the Band”: Listen

    Trinidad Chambliss: Division II Ferris State to breakout star at Ole Miss

    The West shows up as G2 and FlyQuest move one step closer to Worlds 2025 Knockouts

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    © 2025 Earth & Beyond.
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.

    Newsletter Signup

    Subscribe to our weekly newsletter below and never miss the latest product or an exclusive offer.

    Enter your email address

    Thanks, I’m not interested